Orthofix Medical Inc. - Common Stock (OFIX)
15.63
+0.00 (0.00%)
NASDAQ · Last Trade: Dec 9th, 5:35 AM EST
One fund has turned nearly a third of its portfolio into a bet that this beaten-down science supplier is due for a rebound.
Via The Motley Fool · December 7, 2025
Why would a fund step away from a stock that’s quietly building one of the strongest backlogs in federal contracting?
Via The Motley Fool · December 7, 2025
This hedge fund just made a bold bet on a behavioral-health giant in the middle of a reset—here’s what they may be seeing.
Via The Motley Fool · December 7, 2025
Orthofix (OFIX) Q3 2025 earnings beat estimates with $0.20 EPS vs. $(0.41) forecast. Revenue of $205.6M also surpassed expectations, driven by strong spine and orthopedics growth.
Via Chartmill · November 4, 2025
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target.
Via Benzinga · August 18, 2025

Via Benzinga · January 30, 2025

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.
Via Benzinga · January 22, 2025

Via Benzinga · January 22, 2025

Via Benzinga · January 17, 2025

Via Benzinga · November 8, 2024

OFIX stock results show that Orthofix Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 6, 2024

Via Benzinga · May 8, 2024

OFIX stock results show that Orthofix Medical met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 7, 2024

OFIX stock results show that Orthofix Medical missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 5, 2024

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.
Via Benzinga · January 9, 2024

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via Benzinga · March 5, 2024

U.S. stock futures traded lower this morning, with the Dow Jones futures falling more than 50 points on Monday.
Via Benzinga · December 4, 2023

The ride-hailing giant will join the index as part of a quarterly rebalancing.
Via Investor's Business Daily · December 1, 2023
